Sun Pharma Expands China Presence with Shanghai-Based Subsidiary

Image Source : Clival Database

Sun Pharmaceutical Industries Ltd has formally incorporated a dedicated unit in China, marking a strategic step to deepen its footprint in the world’s secondlargest pharmaceutical market.

Key Highlights:

The new entity, Sun Pharma (Shanghai) Co., Ltd., is located in Xuhui District, Shanghai.
It will focus on regulatory development, business expansion, and marketing of Sun Pharma’s portfolio in China.
The company has already registered several products and is collaborating with local firms to enhance distribution.

Strategic Context:

Sun Pharma’s entry into China aligns with its global expansion strategy across 100+ countries.
The Shanghai unit will leverage support from Sun’s global R&D and 43 manufacturing facilities across six continents.
The move follows earlier licensing deals with China Medical System Holdings for specialty drugs like Cyclosporine eye drops and Tildrakizumab.

Operational Impact:

The subsidiary will help streamline product approvals and improve access to affordable medicines in China.

Sources: SunPharma.com, NDTV Profit, Economic Times.